Explore Supplements Subscribe
The VerdictMODERATE CONVICTIONWorth-It: Situational ROI (55/100)

Selenium works for the deficient and Hashimoto's patients — for everyone else in North America, it may actually increase cancer risk.

Ask yourself: Have you tested your blood selenium levels recently — or do you live outside North America? If yes to either, a short trial may be worth discussing with your doctor. If no — skip it. You almost certainly don't need it, and supplementing may cause real harm.

Selenium is a trace mineral your thyroid treats like gold — the gland holds more of it per gram of tissue than any other organ. Your thyroid needs it to convert inactive thyroid hormone into the active form your body can use, and to protect its own cells from the chemical reaction that makes hormones in the first place. The problem is that most people aren't short of it. And when you add more to a system that's already full, the mechanism flips — you get oxidative stress where you wanted antioxidant protection, and a 35,000-person trial found it increased aggressive prostate cancer risk in replete men.

That's the general answer. Your stack is different.

Check your whole stack
SH
Dr. Seth Holbrook, DPT — Doctor of Physical Therapy • Coach to 300+ clients
I built The Verdict to cut through recycled health advice and show what the evidence actually supports.

The Verdict Research • Vitamins & Minerals

Selenium

Essential Trace Mineral — Thyroid Cofactor

CONDITIONAL

Ask yourself: Have you confirmed low blood selenium — or do you have Hashimoto's thyroiditis? If yes, a short trial may be worth discussing with your doctor. If no, skip the supplement and eat tuna or turkey twice a week instead.

Selenium is one of the few supplements where the same dose that helps one person can actively harm another — the difference is simply whether you're deficient or not.

Takes 30 seconds to answer. Could save you money and real risk.

The Verdict

Selenium works for the deficient and Hashimoto's patients — for replete North Americans, it may increase cancer risk.

Selenium is an essential trace mineral your body uses like a precision tool — not a fuel, but a key component in 25 specialized proteins your cells can't make any other way. Your thyroid, which holds more selenium per gram than any organ in the body, uses it to convert inactive thyroid hormone into its active form, and to protect itself from the chemical reaction that makes hormones in the first place. The problem is that most people aren't short of it. When you add more selenium to a system that's already full, the mechanism flips — selenium starts generating the kind of cell damage it was supposed to prevent. A 35,000-person trial confirmed this: supplementing in people who already had enough raised aggressive prostate cancer and type 2 diabetes risk instead of lowering them.

  1. The verdict: The largest selenium trial ever run (N=35,533, SELECT, JAMA 2011) found that 200 mcg/day offered zero cancer prevention in selenium-replete adults, and actively increased high-grade prostate cancer risk and type 2 diabetes risk in those who started with the most selenium.
  2. What most people get wrong: The daily requirement for selenium is 55 mcg — you only need about 4 standard supplements to hit the level at which hair loss and disease risk start to appear (255 mcg/day EFSA upper limit), and most North Americans already get 100–120 mcg from food alone.
  3. Protocol in plain English: If you're in the UK, Europe, Australia, or New Zealand (or have confirmed deficiency below 100 µg/L blood): 100–200 mcg/day selenomethionine with food; if you have Hashimoto's: 200 mcg/day for a 6-month monitored trial; everyone else: eat tuna, turkey, or 1–2 Brazil nuts per week — you're covered.

Best for

People with confirmed selenium deficiency (common in UK, Europe, Australia, New Zealand) · Hashimoto's thyroiditis patients · Those starting high-dose iodine supplementation

Skip if

You live in North America without confirmed low levels · You haven't tested blood selenium · Men concerned about prostate cancer · Anyone on chemotherapy

Want the full evidence? Keep scrolling

The Protocol

Selenium protocol

Dosing is highly population-dependent. The critical variable is your baseline plasma selenium — not your symptoms.

Population Dose Form Duration Source
Selenium-deficient adults (<70 µg/L plasma) 100–200 mcg/day with food L-Selenomethionine Until replete — retest at 3 months NIH ODS
Hashimoto's thyroiditis (adjunct) 200 mcg/day with food Selenomethionine or Sodium Selenite 6-month therapeutic trial — reassess TPO antibodies Gärtner 2002; Cochrane 2013
North American adults (selenium-replete) Dietary only — no supplement Food sources N/A — supplementation contraindicated SELECT trial; Cochrane 2018
Pregnant/lactating women 60–70 mcg/day (RDA) Standard prenatal form Throughout pregnancy NIH ODS; EFSA
Men with idiopathic sperm issues 100–200 mcg/day Selenomethionine 3–6 months — urologist oversight needed Buhling/Ross meta-analysis

Forms Comparison

L-Selenomethionine
~97% bioavailable
Best general form. Active transport via methionine pathway. Non-specific protein incorporation above 200 mcg/day.
£8–15/month
Selenium-Enriched Yeast
~89% bioavailable
Lower cost; slightly variable (54–85% SeMet by batch). Used in NPC trial (cancer prevention in deficient subjects).
£6–12/month
Sodium Selenite
~60% bioavailable
100% functionally utilised (no non-specific protein sink). Used in Hashimoto's trials. CRITICAL: do not take with Vitamin C — blocked completely.
£5–8/month

Absorption Tips

Safety & Interactions

Selenium safety
Narrow therapeutic window. The gap between the daily requirement (55 mcg) and the level at which real harm begins (255 mcg EFSA UL) is only 200 mcg — about 4 standard 50 mcg tablets per day added to a North American diet.

Iodine — SEVERE (if selenium-deficient)

Supplementing high-dose iodine without adequate selenium → GPx failure → unchecked H₂O₂ accumulates → thyrocyte necrosis and autoimmune thyroiditis (Wolff-Chaikoff amplification). Always ensure selenium adequacy before starting iodine loading protocols.

Vitamin C + Sodium Selenite — MODERATE

High-dose Vitamin C taken with sodium selenite reduces selenite to unabsorbable elemental selenium in the GI tract. Affects only the inorganic form — selenomethionine is unaffected. Separate by 2+ hours if using selenite form.

High-dose Vitamin E (>400 IU) — MODERATE

The SELECT trial demonstrated that combining Vitamin E + Selenium in replete men increased prostate cancer risk — Vitamin E alone was associated with a 17% increase. Avoid high-dose antioxidant combination supplements.

Chemotherapy Agents — MODERATE (context-dependent)

Some evidence suggests selenium may have cytoprotective effects on normal tissue during chemotherapy without blunting tumour-killing efficacy — but only under oncologist supervision. Never self-supplement during cancer treatment.

Heavy Metals (Mercury, Arsenic) — MILD (beneficial antagonism)

Selenium binds to mercury and arsenic, forming less toxic selenide-metal complexes. Heavy metal exposure also depletes selenium reserves — supplementation may be warranted in exposed populations after baseline testing.

Selenosis — Toxicity Profile

Early sign: "garlic breath" on the breath (exhalation of dimethyl selenide). Progresses to:

EFSA Tolerable Upper Intake Level (2023): 255 mcg/day (reduced from 300 mcg based on SELECT alopecia data)
NIH Upper Intake Level: 400 mcg/day

Contraindicated Populations

Evidence Confidence

MODERATE

Conviction is MODERATE overall. The harm signal for replete populations is HIGH conviction (N=35,533). The benefit for deficiency correction is HIGH conviction. The Hashimoto's benefit remains MODERATE — antibodies drop reliably, but clinical downstream effects remain unproven long-term.

What would change this verdict
For cancer prevention: A Phase III, double-blind RCT using methylselenocysteine (not selenomethionine) in participants with biochemically confirmed baseline plasma selenium <100 ng/mL, primary endpoint of incident prostate cancer at 7 years, N ≥ 10,000. No such trial is currently underway.

For Hashimoto's: A well-powered, long-term RCT (N > 300, 18+ months) demonstrating reduced levothyroxine dose requirements alongside TPO antibody reduction would upgrade this to HIGH conviction for that indication.

Worth Your Money?

Weekly cost £1.50–£3 per week at 100–200 mcg/day (selenomethionine, one tablet daily)
Worth it if You have a confirmed blood selenium below 100 µg/L, or a Hashimoto's thyroiditis diagnosis — and you're using this as an adjunct to, not a replacement for, your thyroid treatment.
Lower priority if You eat fish, poultry, or eggs regularly — your food almost certainly covers your selenium needs. Your money is better spent on actual dietary improvements first, not a mineral you're probably not short of.
Conditional Value

Stop Guessing

Want to know which supplements are actually worth your money — and which ones are quietly doing harm? The Verdict reviews one every week, free.

Get the weekly review →

Sources

  1. Klein EA et al. (2011). Vitamin E and the risk of prostate cancer: The SELECT Trial. JAMA. N=35,533. 200 mcg/day L-SeMet: zero cancer prevention; increased high-grade prostate cancer risk in highest baseline Se quartile.
  2. Vinceti M et al. (2018). Selenium for preventing cancer. Cochrane Database of Systematic Reviews. N=44,743. No overall cancer prevention benefit; alopecia/dermatitis risk confirmed.
  3. Gärtner R et al. (2002). Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab. N=70. TPOAb −36.4% vs −12% placebo.
  4. Stoppe C et al. (2023). SUSTAIN CSX — Effect of selenium supplementation on postoperative organ dysfunction after cardiac surgery. JAMA Surgery. N=1,416. No benefit for organ dysfunction or 30-day mortality.
  5. Hercberg S et al. (2004). The SU.VI.MAX Study. Arch Intern Med. N=13,017. Cancer benefit only in selenium-deficient men; women showed no benefit.
  6. EFSA Panel on Dietetic Products, Nutrition and Allergies (2023). Scientific Opinion on the Tolerable Upper Intake Level for selenium. EFSA Journal. UL revised to 255 µg/day.
  7. Loef M et al. (2021). Selenium and cognition — Newcastle 85+ Study. No protection against rate of longitudinal cognitive decline.
  8. Kryscio RJ et al. (2017). PREADViSE — Association of antioxidant supplement use and dementia. JAMA Neurol. N=3,786. No prevention of dementia or cognitive decline in replete older men.

Action ROI

Is this worth your time, money, effort, risk, and trust for this goal? Different from Verdict Score (evidence strength) and Leverage Map (relative importance) — Action ROI is the worth-it call once friction is priced in.

Action ROI score
55/100 Situational ROI Trust grade C
Conditional, and only in two narrow cases: a confirmed deficiency or Hashimoto's. For a well-fed North American, it does nothing useful and can do harm.
Time
Low
Money
Low
Effort
Low
Risk
Medium
Why this score
Why it didn’t score higher
Best for
Lower ROI if
Minimum effective dose
Only if deficient or Hashimoto's: 100 to 200mcg/day of selenomethionine or sodium selenite with food, never exceeding 200mcg from supplements (EFSA upper limit 255mcg includes diet). Discontinue once replete; reassess thyroid antibodies at 6 months. Replete adults need dietary selenium only.
Track this

Get the complete dosing protocol

Evidence-scored dosing, timing, forms, and who should skip it. One page, no fluff.

Get the protocol

Related free research

Supplements
Plant Sterols & Stanols — The Verdict
 Supplements
Exogenous Ketones — The Verdict
 Supplements
Serrapeptase — Does the Silkworm Enzyme Actually Work?

There are 424 more inside

Conviction-scored verdicts on supplements, nutrition, training, physio, and recovery.

Explore all Get weekly verdicts